UroGen Pharma
URGN
$13.22
Share price
0.08%
Change (1 day)
11.09%
Change (1 year)
Categories
EPS for UroGen Pharma (URGN)
EPS in 2023 (TTM): -$4.68
According to UroGen Pharma's latest financial reports the company's current EPS (TTM) is -$4.68. In 2022 the company made an earnings per share (EPS) of -$4.78 an increase over its 2021 EPS that were of -$4.96.
EPS history for UroGen Pharma from 2017 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$4.68 | -2.09% |
| 2022 | -$4.78 | -3.63% |
| 2021 | -$4.96 | -16.22% |
| 2020 | -$5.92 | 15.63% |
| 2019 | -$5.12 | 7.56% |
| 2018 | -$4.76 | 160.58% |
| 2017 | -$1.83 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | -53.42% | 🇺🇸 USA |